Dr Mehran has received institutional research funding from Abbott, Abiomed, Alleviant Medical, AM-Pharma, Amgen, Arena, AstraZeneca, Atricure, Bayer, Biosensors, Biotronik, Boston Scientific, Bristol Myers Squibb, CardiaWave, CeloNova, Chiesi, Concept Medical, CSL Behring, Cytosorbents, Daiichi-Sankyo, Element Science, Faraday, Humacyte, Idorsia Pharmaceuticals, Janssen, Medtronic, Novartis, OrbusNeich, PhaseBio, Philips, Pi-Cardia, RenalPro, Shockwave, Vivasure, and Zoll
Clinical trial data show the following side effects related to heartburn: Gastroesophageal reflux disease: 5% of Wegovy users, 3% of the placebo group
GLP-1s may reduce appetite and slow digestion to support weight loss, but lasting risk reduction comes from behavior change
Het organiseren van een feestelijk evenement kan veel tijd kosten